EyePoint Pharmaceuticals
EYPT
EYPT
58 hedge funds and large institutions have $111M invested in EyePoint Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
+13
Holders Change %
+28.89%
% of All Funds
1.26%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
19
Increased
19
Reduced
13
Closed
6
Calls
$140K
Puts
$166K
Net Calls
-$26K
Net Calls Change
-$195K
Top Buyers
1 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$2.66M |
2 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$2.04M |
3 |
Millennium Management
New York
|
+$1.68M |
4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$892K |
5 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$886K |
Top Sellers
1 |
Renaissance Technologies
New York
|
-$524K |
2 |
EI
EAM Investors
Solana Beach,
California
|
-$138K |
3 |
BlackRock
New York
|
-$122K |
4 |
Citadel Advisors
Miami,
Florida
|
-$91.4K |
5 |
BFM
Boothbay Fund Management
New York
|
-$65.3K |